Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 1, 2013, Pages 38-43

  De Meij, T G J ^a   Jharap, B ^b   Kneepkens, C M F ^a   Van Bodegraven, A A ^b   De Boer, N K H ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; MERCAPTOPURINE;

ADULT; ARTICLE; ARTIFICIAL MILK; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; IMMUNE STATUS; INFECTION SENSITIVITY; MALE; MATERNAL TREATMENT; NEWBORN; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; TNO AZL PRESCHOOL CHILDREN QUALITY OF LIFE QUESTIONNAIRE; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ADULT; BREAST FEEDING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS;

EID: 84878796510     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12334     Document Type: Article

References (29)

1. Present DH, Korelitz BI, Wisch N, et al,. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981-7.
2. Timmer A, McDonald JW, Macdonald JK,. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; CD000478.
3. Subhani JM, Hamiliton MI,. Review article: the management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther 1998; 12: 1039-53.
4. Kane S,. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am 2003; 32: 323-40.
5. Mahadevan U,. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 2006; 55: 1198-206. Review.
6. Akbari M, Shah S, Velayos FS, et al,. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 15-22.
7. Bush MC, Patel S, Lapinski RH, et al,. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004; 15: 237-41.
8. Reddy D, Murphy SJ, Kane SV, et al,. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 2008; 103: 1203-9.
9. Connell W, Miller A,. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf 1999; 21: 311-23.
10. De Witte DB, Buick MK, Cyran SE, et al,. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr 1984; 105: 625-8.
11. Davison JM, Dellagrammatikas H, Parkin JM,. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 1985; 92: 233-9.
12. Coté CJ, Meuwissen HJ, Pickering RJ,. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 1974; 85: 324-8.
13. Polifka JE, Friedman JM,. Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002; 65: 240-61.
14. Jharap B, de Boer NK, Stokkers P,. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut 2013; doi: 10.1136 [Epub ahead of print].
15. Sau A, Clarke S, Bass J, et al,. Azathioprine and breastfeeding: is it safe? BJOG 2007; 114: 498-501.
16. Christensen LA, Dahlerup JF, Nielsen MJ, et al,. Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008; 28: 1209-13.
17. Gardiner SJ, Gearry RB, Roberts RL, et al,. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 2006; 62: 453-6.
18. Angelberger S, Reinisch W, Messerschmidt A, et al,. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis 2011; 5: 95-100.
19. Selinger CP, Leong RW, Lal S,. Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective. World J Gastroenterol 2012; 18: 2600-8.
20. Mountifield RE, Prosser R, Bampton P, et al,. Pregnancy and IBD treatment: this challenging interplay from a patients' perspective. J Crohns Colitis 2010; 4: 176-82.
21. Julsgaard M, Nørgaard M, Hvas CL, et al,. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflamm Bowel Dis 2011; 17: 1573-80.
22. Fekkes M, Theunissen NC, Brugman E, et al,. Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res 2000; 9: 961-72.
23. Vogels T, Verrips GH, Verloove-Vanhorick SP, et al,. Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res 1998; 7: 457-65.
24. Cohen J,. Statistical Power Analysis for the Ehavioral Sciences. New York: Academy Press; 1988.
25. Nørgård B, Pedersen L, Fonager K, et al,. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 2003; 17: 827-34.
26. Raatikainen K, Mustonen J, Pajala MO, et al,. The effects of pre- and post pregnancy inflammatory bowel disease diagnosis on birth outcomes. Aliment Pharmacol Ther 2011; 33: 333-9.
27. Langagergaard V, Pedersen L, Gislum M, et al,. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study. Aliment Pharmacol Ther 2007; 25: 73-81.
28. Van Assche G, Dignass A, Reinisch W, et al,. European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010; 4: 63-101.
29. Kane S, Lemieux N,. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005; 100: 102-5.